Infinium Pharmachem Ltd (INFINIUM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: INFINIUM | Chemicals | Small Cap

BSE Share Price
Not Listed

Infinium Pharmachem Ltd (INFINIUM) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: INFINIUM | Chemicals | Small Cap

DeciZen - make an informed investing decision on Infinium Pharmachem

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Infinium Pharmachem stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
44.53
Market Cap:
377.1 Cr.
52-wk low:
0
52-wk high:
0

Is Infinium Pharmachem Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Infinium Pharmachem: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Infinium Pharmachem Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 19.9%31.8%34.4%36.8%29.3%13.2%-
Value Creation
Index
0.41.31.51.61.1-0.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3654.674101122137137
Sales YoY Gr.-51.4%35.7%36.8%20.8%11.9%-
Adj EPS 12.45.38.37.655.4
YoY Gr.-154.7%117.8%57.7%-8.2%-34.5%-
BVPS (₹) 4.36.912.321.341.567.867.8
Adj Net
Profit
12.55.48.510.67.88
Cash Flow from Ops. 2.36.89.17.4-15-26-
Debt/CF from Ops. 3.81.52.53.6-0.5-1.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA30.6%22.7%11.9%
Adj EPS NA39.4%-1.7%-34.5%
BVPSNA74%76.5%63.5%
Share Price - - - -23.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
22.443.454.749.426.79.58
Op. Profit
Mgn %
7.3911.81514.211.1NAN
Net Profit
Mgn %
2.74.57.28.38.75.76.2
Debt to
Equity
2.11.51.81.20.10.4-
Working Cap
Days
01241381371402030
Cash Conv.
Cycle
0505468911270

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Infinium Pharmachem Ltd.

Standalone Consolidated
TTM EPS (₹) 5.4 5.2
TTM Sales (₹ Cr.) 137 156
BVPS (₹.) 67.8 70.3
Reserves (₹ Cr.) 90 94
P/BV 3.57 3.45
PE 44.53 46.30
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 377
Equity (₹ Cr.) 15.6
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Infinium Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Infinium Pharmachem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Infinium Pharmachem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales365574101122137
Operating Expenses 33506586105122
Manufacturing Costs123333
Material Costs2739547194109
Employee Cost 222235
Other Costs 3671164
Operating Profit 359151715
Operating Profit Margin (%) 7.3%9.0%11.8%15.0%14.2%11.1%
Other Income 111122
Interest 112323
Depreciation 111123
Exceptional Items 000000
Profit Before Tax 147121512
Tax 012343
Profit After Tax 1369118
PAT Margin (%) 2.8%5.0%7.4%9.0%9.1%6.2%
Adjusted EPS (₹)1.02.75.49.08.05.4
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 47132258106
Share Capital 11151416
Reserves 3612174490
Minority Interest000000
Debt9112226839
Long Term Debt6614855
Short Term Debt35918334
Trade Payables611109811
Others Liabilities 1244511
Total Liabilities 2131496078166

Fixed Assets

Gross Block788212428
Accumulated Depreciation3345811
Net Fixed Assets 444161617
CWIP 048001
Investments 0000016
Inventories7914182235
Trade Receivables71013152434
Cash Equivalents 0123833
Others Assets 2288630
Total Assets 2131496078166

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 2797-15-26
PBT 147121512
Adjustment 222446
Changes in Working Capital -021-6-30-40
Tax Paid -0-1-2-3-4-3
Cash Flow From Investing Activity -1-5-7-3-3-23
Capex -1-5-5-5-3-4
Net Investments 000-00-15
Others 00-220-3
Cash Flow From Financing Activity -1-1-2-32374
Net Proceeds from Shares 00002541
Net Proceeds from Borrowing 000000
Interest Paid -1-1-2-3-2-3
Dividend Paid 000000
Others 0000-036
Net Cash Flow 0102525

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)23.5947.8756.1753.4327.9210.36
ROCE (%)19.8731.7734.4436.8329.3213.22
Asset Turnover Ratio1.752.131.861.851.771.12
PAT to CFO Conversion(x)22.331.50.78-1.36-3.25
Working Capital Days
Receivable Days756058515878
Inventory Days685156586077
Payable Days808073493231

Infinium Pharmachem Ltd Stock News

Infinium Pharmachem Ltd FAQs

The current trading price of Infinium Pharmachem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Infinium Pharmachem stood at ₹377.1.
The latest P/E ratio of Infinium Pharmachem as of 31-Dec-1969 is 44.53.
The latest P/B ratio of Infinium Pharmachem as of 31-Dec-1969 is 3.57.
The 52-week high of Infinium Pharmachem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Infinium Pharmachem is ₹136.9 ( Cr.) .

About Infinium Pharmachem Ltd

The company was originally incorporated as ‘Infinium Pharmachem Private Limited’ on November 21, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Ahmedabad, Gujarat. Later on, the company was converted into public limited company, the name of the company was changed to ‘Infinium Pharmachem Limited’ and fresh Certificate of Incorporation dated August 12, 2022 was issued by the Registrar of Companies, Ahmedabad, Gujarat.

The company was incorporated with the objective of manufacturing and supplying of various pharma related chemicals, bulk drugs, pharma intermediates etc. Accordingly, the company is dealing specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs). The company was formed with a vision to be globally integrated and admired Pharmaceutical & Healthcare Company.

The company undertakes Contract Research and Manufacturing Services (CRAMS) to provide customized and fully confidential solutions to its clients.  Currently, the company’s manufacturing capabilities and technical expertise have efficiently catered numerous industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics and much more. The company has auditable manufacturing facility and it has been audited by various well known pharma giants worldwide. The Company currently provides the widest range of Iodine derivatives in the market, with more than 250 intermediates and over 15 APIs. All its products are developed to meet challenging demands, superior quality, performance and various other commercial requirements across industries.

The company has developed and maintained long - term healthy relationships with all its clients, including Pharmaceutical, Biotech and Fine Chemical companies and its products reach out to over 250+ clients globally. The company formed a Subsidiary Company in the name of Infinium Green Energy Private Limited on June 06th, 2022, The Company also formed a foreign Subsidiary as a Joint Venture (JV) with Shanghai Witofly Chemical Co. Ltd., in the name of Shanghai Tajilin Industrial Co. Ltd., in the People's Republic of China in the year 2019.

Business area of the company

The company is well focused to Iodine chemistry & this is the only core area of it. It is working as CRAMS, but its domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination. It manufactures & supply wide range of superior quality Iodine Derivatives & API Since 2003. It is also providing fully integrated customized services from R&D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & various other chemical Industries. It supplies range of Iodine derivatives on Order to Made basis only.

Major Events

  • 2003: Incorporation of the company viz. ‘Infinium Pharmachem Private Limited’.
  • 2022: Conversion of the company’s status from Private Limited to Limited Company.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×